Experience of tailoring prophylaxis using factor VIII pharmacokinetic parameters estimated with myPKFiT® in patients with severe haemophilia A without inhibitors.
about
Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement.If you know you will also see: population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia.Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH.
P2860
Experience of tailoring prophylaxis using factor VIII pharmacokinetic parameters estimated with myPKFiT® in patients with severe haemophilia A without inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Experience of tailoring prophy ...... mophilia A without inhibitors.
@en
Experience of tailoring prophy ...... mophilia A without inhibitors.
@nl
type
label
Experience of tailoring prophy ...... mophilia A without inhibitors.
@en
Experience of tailoring prophy ...... mophilia A without inhibitors.
@nl
prefLabel
Experience of tailoring prophy ...... mophilia A without inhibitors.
@en
Experience of tailoring prophy ...... mophilia A without inhibitors.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Experience of tailoring prophy ...... mophilia A without inhibitors.
@en
P2093
A L Hernández-Moreno
H de la Corte-Rodríguez
M I Rivas-Pollmar
M Martín-Salces
M T Álvarez-Román
N Butta-Coll
P2860
P304
P356
10.1111/HAE.13141
P577
2017-01-01T00:00:00Z